Gero Overview

  • Year Founded
  • 2018

Year Founded

  • Status
  • Private

  • Employees
  • 20

Employees

  • Latest Deal Type
  • Later Stage VC

  • Latest Deal Amount
  • $17M

  • Investors
  • 5

Gero General Information

Description

Operator of a preclinical-stage biotechnology company intended to create therapeutics against the root causes of age-related and other chronic diseases. The company uses AI to create disease phenotypes in real-world human data and identify diseases with shared biology, enabling medical practitioners to extend a healthy lifespan and delay age-related health issues.

Contact Information

Website
www.gero.ai
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 133 Cecil Street
  • Suite 14-01 Keck Seng Tower
  • Singapore, Singapore 069535
  • Singapore
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Drug Delivery
Other Pharmaceuticals and Biotechnology
Corporate Office
  • 133 Cecil Street
  • Suite 14-01 Keck Seng Tower
  • Singapore, Singapore 069535
  • Singapore

Gero Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Gero Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Later Stage VC 16-Jul-2025 $17M Completed Generating Revenue
3. Later Stage VC (Series A) 18-Oct-2023 Completed Generating Revenue
2. Accelerator/Incubator 15-Jan-2018 $2.2M Completed Startup
1. Early Stage VC (Series A) 08-May-2020 $2.2M $2.2M Completed Startup
To view Gero’s complete valuation and funding history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Gero Patents

Gero Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-4291239-A2 Compounds, compositions and methods for treating age-related diseases and conditions Pending 10-Feb-2021
EP-4291239-A4 Compounds, compositions and methods for treating age-related diseases and conditions Pending 10-Feb-2021
WO-2022173333-A2 Compounds, compositions and methods for treating age-related diseases and conditions Inactive 10-Feb-2021
WO-2022173334-A2 Methods, compositions and compounds for treating age-related diseases and conditions Inactive 10-Feb-2021
US-20230190748-A1 Compositions for treatment of aged diseases Inactive 27-Mar-2020 A61K31/517
To view Gero’s complete patent history, request access »

Gero Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Gero Investors (5)

Investor Name Investor Type Holding Investor Since Participating Rounds
Angel (individual) Minority
Melnichek Investments Venture Capital Minority
VitaDAO Venture Capital Minority
Bulba Ventures Venture Capital Minority
FinTech Innovation Lab Accelerator/Incubator Minority
To view Gero’s complete investors history, request access »

Gero FAQs

  • When was Gero founded?

    Gero was founded in 2018.

  • Where is Gero headquartered?

    Gero is headquartered in Singapore, Singapore.

  • What is the size of Gero?

    Gero has 20 total employees.

  • What industry is Gero in?

    Gero’s primary industry is Drug Discovery.

  • Is Gero a private or public company?

    Gero is a Private company.

  • What is Gero’s current revenue?

    The current revenue for Gero is .

  • How much funding has Gero raised over time?

    Gero has raised $25.2M.

  • Who are Gero’s investors?

    , Melnichek Investments, VitaDAO, Bulba Ventures, and FinTech Innovation Lab have invested in Gero.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process